K
Kolon Life Science Inc
KOSDAQ:102940
Kolon Life Science Inc
KOSDAQ:102940
Price:
22 050 KRW
-0.45%
Market Closed
Updated:
May 18, 2024
Balance Sheet
Balance Sheet Decomposition
Kolon Life Science Inc
Kolon Life Science Inc
| Current Assets | 105B |
| Cash & Short-Term Investments | 7.5B |
| Receivables | 25.6B |
| Other Current Assets | 71.9B |
| Non-Current Assets | 204.4B |
| Long-Term Investments | 79.9B |
| PP&E | 123.1B |
| Intangibles | 332.5m |
| Other Non-Current Assets | 996m |
| Current Liabilities | 128.3B |
| Accounts Payable | 11.5B |
| Accrued Liabilities | 4.4B |
| Short-Term Debt | 97.3B |
| Other Current Liabilities | 15.2B |
| Non-Current Liabilities | 43.4B |
| Long-Term Debt | 10.2B |
| Other Non-Current Liabilities | 33.3B |
Balance Sheet
Kolon Life Science Inc
Kolon Life Science Inc
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
5 060
|
27 009
|
137 740
|
55 825
|
32 671
|
5 914
|
15 001
|
27 800
|
6 371
|
7 480
|
|
| Cash Equivalents |
5 060
|
27 009
|
137 740
|
55 825
|
32 671
|
5 914
|
15 001
|
27 800
|
6 371
|
7 480
|
|
| Short-Term Investments |
0
|
0
|
111
|
23 000
|
5 100
|
15 000
|
30
|
110
|
0
|
0
|
|
| Total Receivables |
18 941
|
17 273
|
21 469
|
21 943
|
24 685
|
29 507
|
22 647
|
20 304
|
30 029
|
25 634
|
|
| Accounts Receivables |
17 893
|
17 212
|
21 395
|
20 972
|
23 127
|
29 022
|
22 199
|
19 921
|
29 584
|
24 822
|
|
| Other Receivables |
1 048
|
61
|
74
|
971
|
1 558
|
485
|
448
|
383
|
445
|
812
|
|
| Inventory |
42 592
|
36 251
|
34 734
|
46 532
|
37 427
|
36 064
|
42 790
|
45 998
|
68 494
|
67 777
|
|
| Other Current Assets |
2 265
|
1 845
|
2 761
|
3 676
|
5 833
|
8 805
|
20 094
|
3 809
|
5 291
|
4 154
|
|
| Total Current Assets |
68 857
|
82 379
|
196 816
|
150 976
|
105 717
|
95 290
|
100 563
|
98 021
|
110 184
|
105 045
|
|
| PP&E Net |
113 064
|
116 686
|
125 562
|
144 249
|
166 350
|
178 398
|
141 893
|
131 481
|
125 960
|
123 138
|
|
| PP&E Gross |
113 064
|
116 686
|
125 562
|
144 249
|
166 350
|
178 398
|
141 893
|
131 481
|
125 960
|
123 138
|
|
| Accumulated Depreciation |
25 000
|
34 161
|
40 182
|
50 582
|
67 978
|
80 978
|
92 290
|
106 538
|
113 901
|
122 880
|
|
| Intangible Assets |
7 800
|
10 411
|
11 808
|
17 140
|
8 426
|
900
|
722
|
502
|
343
|
333
|
|
| Goodwill |
2 992
|
2 992
|
2 992
|
2 992
|
1 894
|
1 217
|
1 217
|
1 217
|
1 217
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
|
| Long-Term Investments |
14 656
|
14 656
|
14 545
|
400 520
|
335 701
|
2 140
|
3 262
|
2 549
|
75 240
|
79 924
|
|
| Other Long-Term Assets |
1 526
|
1 491
|
2 848
|
920
|
815
|
350
|
671
|
889
|
1 174
|
996
|
|
| Other Assets |
2 992
|
2 992
|
2 992
|
2 992
|
1 894
|
1 217
|
1 217
|
1 217
|
1 217
|
0
|
|
| Total Assets |
208 896
N/A
|
228 616
+9%
|
354 573
+55%
|
716 797
+102%
|
618 903
-14%
|
278 295
-55%
|
248 338
-11%
|
234 658
-6%
|
314 118
+34%
|
309 436
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
7 134
|
7 532
|
10 277
|
11 701
|
10 268
|
10 714
|
11 808
|
13 774
|
17 049
|
11 547
|
|
| Accrued Liabilities |
1 384
|
1 380
|
1 417
|
1 601
|
1 943
|
1 898
|
2 721
|
3 145
|
3 594
|
4 355
|
|
| Short-Term Debt |
11 903
|
11 574
|
13 444
|
30 417
|
32 940
|
53 742
|
61 751
|
59 064
|
69 461
|
97 262
|
|
| Current Portion of Long-Term Debt |
13 675
|
14 550
|
28 917
|
8 233
|
7 512
|
6 753
|
5 682
|
5 670
|
4 288
|
429
|
|
| Other Current Liabilities |
3 439
|
3 405
|
16 157
|
11 105
|
24 346
|
53 065
|
63 189
|
13 816
|
15 185
|
14 748
|
|
| Total Current Liabilities |
37 536
|
38 441
|
70 212
|
63 056
|
77 009
|
126 173
|
145 152
|
95 469
|
109 578
|
128 341
|
|
| Long-Term Debt |
30 476
|
48 242
|
18 625
|
10 392
|
24 615
|
18 237
|
9 595
|
4 191
|
167
|
10 172
|
|
| Deferred Income Tax |
0
|
0
|
0
|
90 763
|
68 297
|
0
|
0
|
0
|
9 760
|
9 874
|
|
| Other Liabilities |
4 710
|
6 492
|
5 948
|
7 173
|
2 836
|
32 864
|
35 633
|
35 588
|
26 890
|
23 377
|
|
| Total Liabilities |
72 721
N/A
|
93 174
+28%
|
94 784
+2%
|
171 384
+81%
|
172 757
+1%
|
177 274
+3%
|
190 381
+7%
|
135 248
-29%
|
146 395
+8%
|
171 764
+17%
|
|
| Equity | |||||||||||
| Common Stock |
3 345
|
3 345
|
3 805
|
3 805
|
5 706
|
5 706
|
5 706
|
5 706
|
5 706
|
5 706
|
|
| Retained Earnings |
76 763
|
76 031
|
86 412
|
83 314
|
32 666
|
61 361
|
104 359
|
106 024
|
101 537
|
133 289
|
|
| Additional Paid In Capital |
56 417
|
56 417
|
169 922
|
169 922
|
167 980
|
167 980
|
167 980
|
209 542
|
209 114
|
209 114
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
288 722
|
240 606
|
10 493
|
10 557
|
9 001
|
54 440
|
56 140
|
|
| Treasury Stock |
351
|
351
|
351
|
351
|
813
|
813
|
813
|
813
|
0
|
0
|
|
| Total Equity |
136 175
N/A
|
135 442
-1%
|
259 788
+92%
|
545 412
+110%
|
446 146
-18%
|
101 020
-77%
|
57 957
-43%
|
99 410
+72%
|
167 723
+69%
|
137 672
-18%
|
|
| Total Liabilities & Equity |
208 896
N/A
|
228 616
+9%
|
354 573
+55%
|
716 797
+102%
|
618 903
-14%
|
278 295
-55%
|
248 338
-11%
|
234 658
-6%
|
314 118
+34%
|
309 436
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
10
|
10
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
